UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 6, 2015

 

NATURE’S SUNSHINE PRODUCTS, INC.

(Exact name of registrant specified in its charter)

 

Utah

 

001-34483

 

87-0327982

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

2500 West Executive Parkway, Suite 100, Lehi, Utah

 

84043

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone, including area code:  (801) 341-7900

 

N/A

(Former name and former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02                                           Results of Operations and Financial Condition.

 

On May 7, 2015, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2015. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 5.07                                           Submission of Matters to a Vote of Security Holders

 

On May 6, 2015, the Company held its annual general meeting of shareholders, at which the following items were voted upon:

 

(1)         Election of Directors. The Company’s shareholders elected all persons nominated for election as directors as set forth in the Proxy Statement to serve until the next Annual Meeting of Shareholders. The following table sets forth the vote of the shareholders at the meeting with respect to the election of directors:

 

Nominee

 

For

 

Withheld

 

Broker
Non-Vote

 

 

 

 

 

 

 

 

 

Li Dong Jui

 

14,467,601

 

116,555

 

1,730,896

 

Albert R. Dowden

 

12,967,748

 

1,616,408

 

1,730,896

 

Kristine F. Hughes

 

12,621,552

 

1,962,604

 

1,730,896

 

Robert B. Mercer

 

13,720,913

 

863,243

 

1,730,896

 

Willem Mesdag

 

13,180,824

 

1,403,332

 

1,730,896

 

Gregory L. Probert

 

13,741,747

 

842,409

 

1,730,896

 

Mary Beth Springer

 

13,721,979

 

862,177

 

1,730,896

 

Rebecca L. Steinfort

 

14,513,831

 

70,325

 

1,730,896

 

Jeffrey D. Watkins

 

13,723,701

 

860,455

 

1,730,896

 

 

(2)         Ratification of appointment of independent registered public accounting firm. The Company’s shareholders voted upon and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accountants for fiscal 2015. The following table sets forth the vote of the shareholders at the meeting with respect to the appointment of Deloitte & Touche LLP:

 

For

 

Against

 

Abstain

 

16,157,241

 

150,595

 

7,216

 

 

There were no broker non-votes in the ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accountants for fiscal 2015.

 

(3)         Advisory Resolution on Executive Officer Compensation. The Company’s shareholders, on an advisory basis, voted to approve an advisory resolution of the compensation of the Company’s named executive officers:

 

For

 

Against

 

Abstain

 

Broker Non-Vote

 

13,914,086

 

621,646

 

48,424

 

1,730,896

 

 

Item 8.01                                           Other Events.

 

Quarterly Cash Dividend

 

On May 7, 2015, the Company issued a press release announcing that its Board of Directors had approved the Company’s payment of a quarterly cash dividend of $0.10 per share, payable on June 2, 2015, to shareholders of record on May 22, 2015.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

2



 

Item 9.01                                           Financial Statements and Exhibits.

 

The following documents are filed as exhibits to this report:

 

Item No.

 

Exhibit

99.1

 

Press Release issued by Nature’s Sunshine Products, Inc., dated May 7, 2015

 

Cautionary Statement Regarding Forward-Looking Statements

 

This report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements relating to our objectives, plans and strategies. All forward-looking statements are based on current expectations and speak only as of the date of this Form 8-K and are expressly qualified in their entirety by the cautionary statements included in our Annual Report on Form 10-K.  The Company cautions investors not to place undue reliance on forward-looking statements, which reflect our analysis only as of the date of this filing.  Except as required by law, we undertake no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances.  Further information on these factors and other factors that could affect the Company’s financial results is included in our filings with the United States Securities & Exchange Commission, including our latest Annual Report on Form 10-K.

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NATURE’S SUNSHINE PRODUCTS, INC.

 

 

 

 

Dated: May 8, 2015

By:

/s/ Steve Bunker

 

 

Steve Bunker, Chief Financial Officer

 

4